SCHEMBL3726176

SCHEMBL3726176

O=Cc1ccc(OC2CCOC2)cc1I

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.40
PDE2A O00408 2/20 0.38
PDE10A Q9Y233 2/20 0.38
ALK Q9UM73 1/20 0.36
GPR119 Q8TDV5 1/20 0.35
LRRK2 Q5S007 2/20 0.35
PDE4A P27815 3/20 0.34
PDE4B Q07343 3/20 0.34
PDE4C Q08493 3/20 0.34
PDE4D Q08499 3/20 0.34
ACACB O00763 3/20 0.34
FGFR4 P22455 1/20 0.34
GRM5 P41594 2/20 0.34
SLC5A1 P13866 1/20 0.34
SLC5A2 P31639 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26345001 0.81 ACACB (0.40) HRH3PDE2APDE10AALKLRRK2
SCHEMBL29416754 0.81 ACACB (0.40) HRH3PDE2APDE10AALKLRRK2
SCHEMBL26345034 0.81 ACACB (0.40) HRH3PDE2APDE10AALKLRRK2
SCHEMBL29416716 0.81 ACACB (0.40) HRH3PDE2APDE10AALKLRRK2
SCHEMBL28703678 0.81 ACACB (0.40) HRH3PDE2APDE10AALKLRRK2
SCHEMBL28376456 0.76 ALDH1A1 (0.56) HRH3ACACBSLC5A1SLC5A2
SCHEMBL20576262 0.76 ALDH1A1 (0.56) HRH3ACACBSLC5A1SLC5A2
SCHEMBL924708 0.76 ALDH1A1 (0.56) HRH3ACACBSLC5A1SLC5A2
SCHEMBL28376632 0.74 SRC (0.42) HRH3ACACBGRM5
SCHEMBL29588562 0.74 SRC (0.42) HRH3ACACBGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2242741-A1 CYCLOALKOXY-SUBSTITUTED 4-PHENYL-3,5-DICYANOPYRIDINES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2010-10-27 EP disclosed
WO-2009100827-A1 CYCLOALKOXY-SUBSTITUTED 4-PHENYL-3,5-DICYANOPYRIDINES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-08-20 WO disclosed